Oragenics (OGEN) Operating Expenses (2010 - 2026)

Oragenics (OGEN) has reported Operating Expenses for 17 consecutive years, with $2.6 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 51.24% year-over-year to $2.6 million; the trailing twelve-month figure through Jun 2026 stood at $10.5 million (up 9.83% YoY), and the FY2025 full-year result was $9.4 million, down 11.33% from the prior year.
• Operating Expenses improved to $2.6 million in Q2 2026 per OGEN's latest filing, from $2.3 million in the prior quarter.
• Across five years, Operating Expenses topped out at $12.8 million in Q4 2023 and bottomed at $1.7 million in Q2 2025.
• Historically, Operating Expenses has averaged $3.3 million across 5 years, with a median of $2.5 million in 2025.
• The sharpest annual moves came in 2023 and 2024: Operating Expenses jumped 456.56% in 2023, then tumbled 73.78% in 2024.
• Over 5 years, Operating Expenses stood at $2.3 million in 2022, then surged by 456.56% to $12.8 million in 2023, then sank by 73.78% to $3.4 million in 2024, then fell by 25.54% to $2.5 million in 2025, then rose by 3.77% to $2.6 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $2.6 million, $2.3 million, and $2.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.